Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Multicentric Study for External Validation of a Deep Learning Model for Mammographic Breast Density Categorization

19 augusti 2021 uppdaterad av: Hospital Italiano de Buenos Aires
The correct categorization of breast density is essential to adapt the diagnostic examination to the needs of each patient. Assessment of breast density is performed visually by radiologists. Some authors have detected that this method involves considerable intra and interobserver variability. On the other hand, automated systems for measuring breast density are becoming more and more frequent. Machine learning is a domain of Artificial Intelligence, which comprises the process of developing systems with the ability to learn and make predictions using data. These systems are designed to aid healthcare professional decision making. In the present work, the multicenter study of external validation of a tool based on deep learning for the categorization of mammographic breast density is proposed.

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Detaljerad beskrivning

The correct categorization of breast density is essential to adapt the diagnostic examination to the needs of each patient. Assessment of breast density is performed visually by radiologists. Some authors have detected that this method involves considerable intra and interobserver variability. On the other hand, automated systems for measuring breast density are becoming more and more frequent. Consequently, in clinical practice, breast density is reported from the assessment carried out by specialists with the support of these systems. But there are few studies about the use, concordance and perception of usefulness of professionals on these tools. A study carried out at the Hospital Italiano de Buenos Aires reported a moderate to almost perfect inter- and intra-observer agreement among radiologists and a moderate concordance between the categorization carried out by experts and that carried out by commercial software of a digital mammography machine. Machine learning is a domain of Artificial Intelligence, which comprises the process of developing systems with the ability to learn and make predictions using data. Once a system designed to aid healthcare professional decision making is developed, it must be validated. In 2019, an internal validation of a tool based on deep learning techniques was carried out for the automatic categorization of mammographic breast density. The tool reached a very good interobserver agreement, kappa = 0.64 (95% CI 0.58-0.69), when compared with the performance of the professionals. It reached a sensitivity of 83.2 (CI: 76.9-88.3) and a specificity of 88.4 (83.9-92.0.) In the present work, the multicenter study of external validation of a tool based on deep learning for the categorization of mammographic breast density is proposed. The evaluation of this tool will be carried out in two external institutions: Hospital Alemán and Fundación Científica del Sur.

Studietyp

Observationell

Inskrivning (Förväntat)

277

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

The unit of analysis will be the bilateral mammographic images with mediolateral oblique and craniocaudal views. The images selected for this study will be screening mammograms performed at Saint John's Cancer Institute. The institution will select the images according to the inclusion and exclusion criteria. The images will be extracted from the institutional database retrospectively and will be anonymized without any personal data, except for the age of the patient. These images will be stored in DICOM format, in a safe place with restricted access limited only to the investigation team.

Beskrivning

Inclusion Criteria:

  • Mammograms included in the study should meet the following criteria:

    • Female patients of 40 years of age or more.
    • To have at least one screening mammography exam performed at Saint John's
    • Cancer Institute during the study period. These exams will be included regardless of the brand of the mammography equipment.
    • Mammograms should be performed with digital equipment.

Exclusion Criteria:

  • Mammograms with the following criteria will be excluded from the study:

    • Patients with gigantomastia, defined by the need for more than one image of each mammographic view (mediolateral oblique and craniocaudal) to evaluate the entire breast volume.
    • Patients with breast implants.
    • Patients with a history of breast surgery.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Agreement between the majority report and Artemisia´s categorization of dense breasts/non-dense breasts
Tidsram: 2 months
The agreement between the CNN and the total of the professionals' categorizations will be calculated with the linear weighted kappa. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images.
2 months
Agreement between the majority report and Artemisia in each one of the four breast density categories
Tidsram: 2 months
For each one of the professionals involved in the study, the agreement with the CNN will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images.
2 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Agreement between each observer and Artemisia´s categorization of dense breasts/non-dense breasts
Tidsram: 2 months
To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images.
2 months
Agreement between each observer and Artemisia in each one of the four breast density categories
Tidsram: 2 months
For each one of the professionals involved in the study, the agreement with the CNN will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by Artemisia for the same set of images.
2 months
Agreement between each observer and the majority report in the categorization of dense breasts/non-dense breasts
Tidsram: 2 months
For each one of the professionals involved in the study, the agreement with the majority report will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by the majority report for the same set of images.
2 months
Agreement between each observer and the majority report in each one of the four breast density categories
Tidsram: 2 months
For each one of the professionals involved in the study, the agreement with the majority report will be calculated with the linear weighted kappa coefficient. To this end, the categories assigned by the professionals will be considered as only one observer in each one of the studies and they will be compared to those assigned by the majority report for the same set of images.
2 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Daniel R Luna, MD, Hospital Italiano de Buenos Aires

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Förväntat)

1 september 2021

Primärt slutförande (Förväntat)

1 april 2022

Avslutad studie (Förväntat)

1 juli 2022

Studieregistreringsdatum

Först inskickad

19 augusti 2021

Först inskickad som uppfyllde QC-kriterierna

19 augusti 2021

Första postat (Faktisk)

25 augusti 2021

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

25 augusti 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

19 augusti 2021

Senast verifierad

1 juli 2021

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Bröstcancer

3
Prenumerera